Influenza DNA vaccine (Merck Sharp & Dohme)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza DNA vaccine (Merck Sharp & Dohme)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Sharp & Dohme Corp

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A